Improving the oral delivery of benznidazole nanoparticles by optimizing the formulation parameters through a design of experiment and optimization strategy-Reference-Cited by-同舟云学术

Improving the oral delivery of benznidazole nanoparticles by optimizing the formulation parameters through a design of experiment and optimization strategy

Published:2022-09 Issue: Volume:217 Page:112678
ISSN:0927-7765
Container-title:Colloids and Surfaces B: Biointerfaces
language:en
Short-container-title:Colloids and Surfaces B: Biointerfaces

Author:

Arrua Eva C.,Hartwig Olga,Loretz Brigitta,Goicoechea Héctor,Murgia Xabier,Lehr Claus-Michael,Salomon Claudio J.

Funder

Horizon 2020

Deutscher Akademischer Austauschdienst France

Universidad Nacional de Rosario

Consejo Nacional de Investigaciones Científicas y Técnicas

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry,Physical and Theoretical Chemistry,Surfaces and Interfaces,General Medicine,Biotechnology

Reference58 articles.

1. Socio-Cultural Aspects of Chagas Disease: A Systematic Review of Qualitative Research

Advances in nanocarriers as drug delivery systems in Chagas disease

3. Chagas disease in Europe: A review for the internist in the globalized world

4. Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: A review

5. Nano-Medicines a Hope for Chagas Disease!

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organic solvent-free benznidazole nanosuspension as an approach to a novel pediatric formulation for Chagas disease;Therapeutic Delivery;2024-08-05

2. Supramolecular eutectogel as new oral paediatric delivery system to enhance benznidazole bioavailability;International Journal of Pharmaceutics;2024-08

3. Nanomedicines against Chagas disease: a critical review;Beilstein Journal of Nanotechnology;2024-03-27

4. Organic solvent-free Benznidazole nanosuspension as an approach to a novel pediatric formulation for Chagas disease;2023-11-02

5. First-Row Transition 7-Oxo-5-phenyl-1,2,4-triazolo[1,5-a]pyrimidine Metal Complexes: Antiparasitic Activity and Release Studies;Pharmaceuticals;2023-09-28